(Q38862440)

English

Longitudinal outcomes in a cohort of Ugandan children randomized to artemether-lumefantrine versus dihydroartemisinin-piperaquine for the treatment of malaria

scientific article

In more languages

default for all languages

No label defined

No description defined

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

7 September 2017

Longitudinal outcomes in a cohort of Ugandan children randomized to artemether-lumefantrine versus dihydroartemisinin-piperaquine for the treatment of malaria (English)

1 reference

Europe PubMed Central

PubMed publication ID

7 September 2017

0 references

0 references

1 reference

based on heuristic

inferred from title

Emmanuel Arinaitwe

3

object named as

Emmanuel Arinaitwe

1 reference

Europe PubMed Central

PubMed publication ID

7 September 2017

10

object named as

Grant Dorsey

1 reference

Europe PubMed Central

PubMed publication ID

7 September 2017

8

object named as

Moses R Kamya

1 reference

Europe PubMed Central

PubMed publication ID

7 September 2017

Philip J Rosenthal

7

object named as

Philip J Rosenthal

1 reference

Europe PubMed Central

PubMed publication ID

7 September 2017

Jordan W Tappero

9

object named as

Jordan W Tappero

1 reference

Europe PubMed Central

PubMed publication ID

7 September 2017

author name string

Humphrey Wanzira

1

1 reference

Europe PubMed Central

PubMed publication ID

7 September 2017

Abel Kakuru

2

1 reference

Europe PubMed Central

PubMed publication ID

7 September 2017

Victor Bigira

4

1 reference

Europe PubMed Central

PubMed publication ID

7 September 2017

Mary K Muhindo

5

1 reference

Europe PubMed Central

PubMed publication ID

7 September 2017

Melissa Conrad

6

1 reference

Europe PubMed Central

PubMed publication ID

7 September 2017

language of work or name

0 references

publication date

13 May 2014

1 reference

Europe PubMed Central

PubMed publication ID

7 September 2017

Clinical Infectious Diseases

1 reference

Europe PubMed Central

PubMed publication ID

7 September 2017

59

1 reference

Europe PubMed Central

PubMed publication ID

7 September 2017

4

1 reference

Europe PubMed Central

PubMed publication ID

7 September 2017

509-516

1 reference

Europe PubMed Central

PubMed publication ID

7 September 2017

A head-to-head comparison of four artemisinin-based combinations for treating uncomplicated malaria in African children: a randomized trial

1 reference

https://api.crossref.org/works/10.1093%2FCID%2FCIU353

21 January 2018

Artemether-lumefantrine versus dihydroartemisinin-piperaquine for falciparum malaria: a longitudinal, randomized trial in young Ugandan children

1 reference

https://api.crossref.org/works/10.1093%2FCID%2FCIU353

21 January 2018

Artemether-lumefantrine versus dihydroartemisinin-piperaquine for treating uncomplicated malaria: a randomized trial to guide policy in Uganda

1 reference

https://api.crossref.org/works/10.1093%2FCID%2FCIU353

21 January 2018

Randomized comparison of amodiaquine plus sulfadoxine-pyrimethamine, artemether-lumefantrine, and dihydroartemisinin-piperaquine for the treatment of uncomplicated Plasmodium falciparum malaria in Burkina Faso

1 reference

https://api.crossref.org/works/10.1093%2FCID%2FCIU353

21 January 2018

World Antimalarial Resistance Network I: clinical efficacy of antimalarial drugs

1 reference

https://api.crossref.org/works/10.1093%2FCID%2FCIU353

21 January 2018

Artemisinin combination therapies for treatment of uncomplicated malaria in Uganda

1 reference

https://api.crossref.org/works/10.1093%2FCID%2FCIU353

21 January 2018

Protective efficacy of co-trimoxazole prophylaxis against malaria in HIV exposed children in rural Uganda: a randomised clinical trial

1 reference

https://api.crossref.org/works/10.1093%2FCID%2FCIU353

21 January 2018

Combination therapy for uncomplicated falciparum malaria in Ugandan children: a randomized trial

1 reference

https://api.crossref.org/works/10.1093%2FCID%2FCIU353

21 January 2018

Amodiaquine alone, amodiaquine+sulfadoxine-pyrimethamine, amodiaquine+artesunate, and artemether-lumefantrine for outpatient treatment of malaria in Tanzanian children: a four-arm randomised effectiveness trial

1 reference

https://api.crossref.org/works/10.1093%2FCID%2FCIU353

21 January 2018

Artemether-lumefantrine versus dihydroartemisinin-piperaquine for treatment of malaria: a randomized trial

1 reference

https://api.crossref.org/works/10.1093%2FCID%2FCIU353

21 January 2018

Safety and tolerability of artemether-lumefantrine versus dihydroartemisinin-piperaquine for malaria in young HIV-infected and uninfected children

1 reference

https://api.crossref.org/works/10.1093%2FCID%2FCIU353

21 January 2018

Pharmacokinetic determinants of the window of selection for antimalarial drug resistance

1 reference

https://api.crossref.org/works/10.1093%2FCID%2FCIU353

21 January 2018

Population pharmacokinetics of piperaquine after two different treatment regimens with dihydroartemisinin-piperaquine in patients with Plasmodium falciparum malaria in Thailand

1 reference

https://api.crossref.org/works/10.1093%2FCID%2FCIU353

21 January 2018

Identifiers

10.1093/CID/CIU353

1 reference

Europe PubMed Central

PubMed publication ID

7 September 2017

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

7 September 2017

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q38862440&oldid=1791390413"